← Open Payments lookup

ROBERT CHAMBLISS: Open Payments

NPI 1780611202 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,293 in 46 payments from 15 companies in 2025. Trend: 2023 $186 · 2024 $729 · 2025 $1,293

Food & beverage: $1,112Education: $181
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc7$289
Teva Pharmaceuticals USA, Inc.5$230
Otsuka America Pharmaceutical, Inc.5$209
E.R. Squibb & Sons, L.L.C.3$80
Alkermes, Inc.4$79
ABBVIE INC.5$77
Collegium Pharmaceutical, Inc.4$69
Neurocrine BioSciences, Inc.3$65
Lundbeck LLC3$47
Supernus Pharmaceuticals, Inc.2$43

Products named: SPRAVATO, ABILIFY ASIMTUFII, COBENFY, ARISTADA, VRAYLAR, Jornay PM, REXULTI, INGREZZA.

Industry payments across PA — which companies pay providers there.